Patents by Inventor Leonard Lachman

Leonard Lachman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5498636
    Abstract: This invention relates to a method for treating angina pectoris. Pursuant to this method, a .beta.-adrenergic-blocking agent is administered acutely to a person having angina to provide an essentially immediate, therapeutic amount of bioavailable blocking agent. The invention further relates to a method wherein the blocking agent is nasally administered for this purpose.
    Type: Grant
    Filed: December 2, 1994
    Date of Patent: March 12, 1996
    Assignee: RiboGene, Inc.
    Inventors: Arthur H. Goldberg, Leonard Lachman
  • Patent number: 5387613
    Abstract: This invention relates to the treatment of tachyarrhythmias of supraventricular origin. This condition may safely be treated by nasal administration of a composition comprising propranolol dissolved in a pharmaceutically acceptable, aqueous-based carrier. A total dose of up to 20 mg of propranolol may be administered at one time.
    Type: Grant
    Filed: July 23, 1993
    Date of Patent: February 7, 1995
    Assignee: RiboGene, Inc.
    Inventors: Arthur H. Goldberg, Leonard Lachman
  • Patent number: 5242949
    Abstract: This invention relates to a method for treating classical migraine headaches. Pursuant to this method, a therapeutic amount of .beta.-adrenergic-blocking agent is administered to a person suffering a migraine attack promptly upon onset of aura. The invention further relates to a method wherein the blocking agent is nasally administered.
    Type: Grant
    Filed: March 13, 1992
    Date of Patent: September 7, 1993
    Assignee: Rugby-Darby Group Companies, Inc.
    Inventors: Arthur H. Goldberg, Leonard Lachman